DOI:
10.1055/s-00000012
Endoscopy
LinksClose Window
References
Yu G, Li S, Wan R. et al.
Nafamostat mesilate for prevention of post-ERCP pancreatitis. A meta-analysis of prospective, randomized, controlled trials.
Pancreas 2015;
44: 561-569
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.